Chemoinformaics analysis of (E)-N-(2-HYDROXYETHYL)-3-METHYLSULFANYLPROP-2-ENAMIDE
| Molecular Weight | 161.226 | nRot | 4 |
| Heavy Atom Molecular Weight | 150.138 | nRig | 2 |
| Exact Molecular Weight | 161.051 | nRing | 0 |
| Solubility: LogS | 0.137 | nHRing | 0 |
| Solubility: LogP | 0.006 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 22.9587 |
| nHD | 2 | BPOL | 14.9333 |
| QED | 0.569 |
| Synth | 2.948 |
| Natural Product Likeliness | 0.859 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.029 |
| HIA | 0.039 |
| CACO-2 | -4.937 |
| MDCK | 0.0000112 |
| BBB | 0.92 |
| PPB | 0.0719897 |
| VDSS | 1.035 |
| FU | 0.870102 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.105 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.226 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.182 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.148 |
| CL | 5.807 |
| T12 | 0.915 |
| hERG | 0.018 |
| Ames | 0.025 |
| ROA | 0.758 |
| SkinSen | 0.891 |
| Carcinogencity | 0.349 |
| EI | 0.97 |
| Respiratory | 0.513 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.955695 |